JB CHEMICALS & PHARMACEUTICALS
|
|
BOM : 506943     NSE : JBCHEPHARM     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
May 24,2024 |
Price(EOD): ₹ 1,668.40
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 25,893.57 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
JB CHEMICALS & PHARMACEUTICALS | -9.4% | -8.6% | 72.1% |
SUN PHARMACEUTICAL INDUSTRIES | -2.9% | 0% | 59.6% |
CIPLA | 5.8% | 6.2% | 60.9% |
DR REDDYS LABORATORIES | 0.9% | -1.5% | 32.2% |
ZYDUS LIFESCIENCES | -2.6% | 15.3% | 114.4% |
DIVIS LABORATORIES | 5% | 8% | 25.9% |
MANKIND PHARMA | -2.3% | -14% | 57.7% |
TORRENT PHARMACEUTICALS | -3.4% | -2.7% | 61.2% |
LUPIN | -2.8% | 2.1% | 110.5% |
FUNDAMENTAL ANALYSIS OF JB CHEMICALS & PHARMACEUTICALS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF JB CHEMICALS & PHARMACEUTICALS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
46.85
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 552.64 Cr
[Latest Qtr - Mar2024 - Consolidated Results ] 8.86
P/B Calculated based on Book Value of Rs 2,923.33 Cr
[Latest Year - Mar2024 - Consolidated Results ] 7.43
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 3,484.18 Cr
[Latest Qtr - Mar2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
416% 258% 236% |
SHARE PRICE MOMENTUM OF JB CHEMICALS & PHARMACEUTICALS
JB CHEMICALS & PHARMACEUTICALS vs SENSEX
DEBT OF JB CHEMICALS & PHARMACEUTICALS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2023 2022 2021 Avg_3yrs |
0.23 0.01 0.01 0.08 |
0.23 0.01 0.02 0.09 |
[Last Annual Data : Mar2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF JB CHEMICALS & PHARMACEUTICALS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF JB CHEMICALS & PHARMACEUTICALS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
2.04% -11.2% -10.52% -5.55% |
13.04% 21.07% 34.41% 43.97% |
QtrlyTrend |
2 | |
Latest Qtr: Mar2024 | ||
Quarterly Result Analysis → |
JB CHEMICALS & PHARMACEUTICALS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 500 | 2% | 4.1% | 38.5% |
S&P BSE ALLCAP | 1.9% | 3.9% | 40.2% |
S&P BSE SMALLCAP SELECT INDEX | 1.5% | 4.1% | 46.4% |
S&P BSE 400 MIDSMALLCAP | 1.2% | 5.5% | 59.5% |
S&P BSE MIDSMALLCAP | 1.2% | 5.1% | 63.7% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 500 | 2% | 4% | 39.4% |
NIFTY500 MULTICAP 50:25:25 | 1.6% | 4% | 47.1% |
NIFTY MNC | 1.3% | 9.9% | 43% |
NIFTY MID SMALL400 | 1.2% | 4.8% | 61.6% |
NIFTY PHARMA | 0.7% | 3.6% | 57.7% |
You may also like the below Video Courses
FAQ about JB CHEMICALS & PHARMACEUTICALS
Is JB CHEMICALS & PHARMACEUTICALS good for long term investment?
As on May 24,2024, the Fundamentals of JB CHEMICALS & PHARMACEUTICALS look Strong and hence it may be good for long term investment! See Financial Performance of JB CHEMICALS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is JB CHEMICALS & PHARMACEUTICALS UnderValued or OverValued?
As on May 24,2024, JB CHEMICALS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of JB CHEMICALS & PHARMACEUTICALS ?
As on May 24,2024, the Intrinsic Value of JB CHEMICALS & PHARMACEUTICALS is Rs. 465.99 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 323.60
Fair Value [Median EV / Sales Model] : Rs. 465.99
Fair Value [Median Price / Sales Model] : Rs. 497.04
Estimated Median Fair Value of JB CHEMICALS & PHARMACEUTICALS : Rs. 465.99
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.